Extensive clinical experience with Taxotere® (T) in 1st and 2nd line treatment at 100 mg/m2 in locally advanced or metastatic NSCLC

✍ Scribed by H. Wilke; J. Von Pawel; G.Boon Cher; M. Krzakowski; R. Pirker; S. Morales; D. Tonelli; I. Avril; C. Manegold

• Book ID: 117667967
• Publisher: Elsevier Science
• Year: 1999
• Tongue: English
• Weight: 158 KB
• Volume: 35
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(99)81428-2